Cargando…
Future Perspectives of Newborn Screening for Inborn Errors of Immunity
Newborn screening (NBS) programs continue to expand due to innovations in both test methods and treatment options. Since the introduction of the T-cell receptor excision circle (TREC) assay 15 years ago, many countries have adopted screening for severe combined immunodeficiency (SCID) in their NBS p...
Autores principales: | Blom, Maartje, Bredius, Robbert G. M., van der Burg, Mirjam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628921/ https://www.ncbi.nlm.nih.gov/pubmed/34842618 http://dx.doi.org/10.3390/ijns7040074 |
Ejemplares similares
-
Second Tier Testing to Reduce the Number of Non-actionable Secondary Findings and False-Positive Referrals in Newborn Screening for Severe Combined Immunodeficiency
por: Blom, Maartje, et al.
Publicado: (2021) -
Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program
por: Blom, Maartje, et al.
Publicado: (2018) -
Economic Evaluation of Different Screening Strategies for Severe Combined Immunodeficiency Based on Real-Life Data
por: van den Akker-van Marle, M. Elske, et al.
Publicado: (2021) -
Future of Therapy for Inborn Errors of Immunity
por: Perez, Elena
Publicado: (2022) -
Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations
por: King, Jovanka R., et al.
Publicado: (2023)